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ABSTRACT 
  Background: The prevalence of diabetes mellitus has risen exponentially in the last decade and an increasing number of 
people are using herbal supplements. 
 Objective: We aimed to assess the relative efficacy of three promising herbs as potentially emerging alternative/adjunct 
treatment for diabetes. 
Materials and Methods: One hundred and ninety-two male Sprague-Dawley rats were used. A third of the animals were 
randomly rendered diabetic with alloxan (150 mg/kg), another third injected 50% dextrose (5 g/kg); and the last third constituted 
the controls. The rats were variously administered aqueous leaf extract of Momordica foetida (500 mg/kg), Vernonia 
amygdalina (500 mg/kg) and Tapinanthus butungii (500 mg/kg), glibenclamide (5 mg/kg) chlorpropamide (250 mg/kg), and 
human insulin lente (0.1 I.U./kg). 
Results: Extract of Momordica foetida caused maximal anti-diabetic effect in six hours, Vernonia amygdalina ten hours, while 
Tapinanthus butungii continued to cause reduction after ten hours. The three extracts caused greater blood glucose reductions 
than glibenclamide in the diabetic rats, while exhibiting comparable effects with chlorpropamide and insulin.
Conclusions: Tapinanthus butungii is more effective in lowering blood glucose than Momordica foetida and Vernonia 
amygdalina in alloxan-induced diabetic rats. Leaf extract of Momordica foetida should be useful in rapidly lowering blood 
glucose, while that of Tapinanthus butungii in situations that require more subtle reductions and in conditions in which 
prolonged hypoglycaemic actions are desirable.
Keywords: Mormordica foetida, Vernonia amygdalina, Tapinanthus butungii, Leaf, Alloxan-induced diabetes mellitus.
INTRODUCTION
Diabetes mellitus has been recognized as a clinical syndrome 
since ancient times, and remains a crippling global health problem 
today. It is due to absolute or relative deficiency or diminished 
effectiveness of circulating insulin. It is widespread and is one of 
the most common chronic diseases. Current estimates suggest that 
approximately 246 million people worldwide suffer from diabetes 
 mellitus (1). Despite major inroads into understanding the 
pathophysiology and treatment of this insidious disease, it had 
continued to be a major health problem worldwide. The 
possibility of its management by the oral administration of 
hypoglycaemic agents had   stimulated great interest in recent 
years.  Current therapies seem to be insufficient to prevent 
  diabetic complications, with a two- to four-fold likelihood for 
developing cardiovascular events (2). Despite the large 
 armamentarium presently available, the progressive deterioration 
 of diabetes control is such that treatment is still insufficient, with 
 the majority of type 2 diabetes patients eventually requiring 
 insulin therapy to achieve targeted glycaemic levels (3), and an 
 estimated 75% dying of diabetes-related complications from 
 cardiovascular disease (4). As a result of these limitations,there is 
 a continuous need for the development of novel healthpromotion 
strategies and therapeutic modalities. While physicians advocate 
 aggressive use of drugs to tighten glucose control and attenuate 
 cardiovascular disease risk factors, many patients are more 
inclined toward use of alternative or complementary therapies that 
 include diet, food supplements and herbal medicine. The use of 
 herbs has more than tripled over the last 10 years (5). Little 
scientific evidence exists to support the numerous herbs used to 
improve diabetes and diabetes-related metabolic disorders (6). For 
a long time diabetes patients have been treated orally with several 
medicinal plants or their extracts based on folk medicine (7).  
Based on the World Health Organization recommendations on 
diabetes mellitus (8), investigations of hypoglycaemic agents of 
plant origin used in traditional medicine are important. The use of 
 herbal products for medicinal benefits has playedan important role 
in nearly every culture on earth and for many years, the search for 
anti-diabetic products will continue to focus on plants and other 
natural resources. Investigators have consistently found that 
several plant products showed unique hypoglycaemic activities in 
diabetic animal models. Animal models of diabetes mellitus are of 
two main groups: (a) a genetic insulin-resistant diabetic model 
such as yellow kk mice, db/db mice and Zucker fatty rat; and (b) an 
experimental diabetic model such as streptozotocin- or alloxan-
induced insulin deficiency diabetic model.  An alloxan-induced 
selective decrease in b-cell mass leads to deficient insulin 
secretion by attenuating insulin pulse mass, and associated 
African Journal of Endocrinology and Metabolism Vol.7 No.1  July - December 2008.  
5
decreased hepat ic  insul in  c learance and re la t ive  
hyperglucagonaemia thereby simulating the pattern of islet 
dysfunction observed in type 2 diabetes mellitus (9).  
This present study sought to compare the relative efficacy of 
three plants with type 2 diabetes therapeutic potential, found in 
South-western Nigeria, using alloxan-induced insulin deficiency 
diabetic model. Momordica foetida (of the family Cucurbitaceae) 
is a common inhabitant of forest edges, woodland, wooded 
grassland and riverine fringes. It is a perennial herb with prostrate 
or climbing stems. The plant emits an unpleasant smell when 
crushed. The bright orange, softly spiny fruit splits open into three 
valves, revealing seeds embedded in bright red jelly. Methanolic 
extract of whole part of Momordica foetida has been shown to 
contain a hypoglycaemic principle (foetidin) identical with 
charantin found in Momordica charantia (10,11), an established 
hypoglycaemic plant. Vernonia amygdalina (of the family 
Compositae) has been reported to have anti-hyperglycaemic 
effect (14,15). Major constituents of the extract from the leaves of 
Vernonia amygdalina include sesquiterpene lactones (vernodalin, 
vernolide, hydroxyvernolide), and steroid glucosides 
(vernonioside A1-A4: the bitter-tasting constituents and 
vernonioside B1-B3) (12,13). It has been reported that a 
sesquiterpene lactone isolated from the extract of Ambrosia 
maritima is an effective hypoglycemic agent (16). Tapinanthus 
butungii (of the family Loranthaceae commonly referred to as 
mistletoe) parasitizes on Albizia glaberrima. A wide range of 
biological activity, including causing hypoglycaemia, has been 
ascribed to this group of plants  (17) The aim of this study was to 
assess the relative effects  of aqueous leaf extract of Momordica 
foetida, Vernonia amygdalina and Tapinanthus butungii at 
lowering blood glucose levels in normoglycaemic, 
hyperglycaemic and alloxan-induced diabetic male Sprague-
Dawley rats, with a view to provide basic data concerning their 




Fresh green leaves of Momordica foetida, Vernonia 
amygdalina and Tapinanthus butungii were harvested from the 
garden of the Anatomy Department of the College of Medicine 
and Botanical Garden, University of Lagos in the month of 
September, 2005. The leaves of Momordica foetida and Vernonia 
amygdalina were identified and authenticated by taxonomists in 
the Department of Botany of the University of Lagos, Lagos, 
Nigeria. The Department keeps voucher specimens of the plants in 
its herbaria. Identification and authentication of the leaves of 
Tapinanthus butungii were carried out at the Forestry Research 
Institute of Nigeria, Ibadan, Nigeria, where voucher specimen was 
deposited. The extraction process was carried out in the 
Department of Pharmacognosy, Faculty of Pharmacy, University 
of Lagos, Lagos, Nigeria. Briefly, the       completely air-dried 
leaves of Momordica foetida (500 g), Vernonia amygdalina (500 
g) and Tapinanthus butungii (500 g) were reduced to powdery 
form, which was placed in distilled water and allowed to boil, 
simmering for one hour. The water extract was dialyzed and the 
internal solution lyophilized. The powder obtained (Momordica 
foetida [3.00 g, 0.60% yield]; Vernonia amygdalina [5.05 g, 
1.10% yield] and Tapinanthus butungii [9.50 g, 1.90% yield]) was 
stored at 4 °C before use and was prepared in distilled water for 
pharmacological studies. The treated animals had each of the 
extract at the dose of 500 mg/kg body weight. 
Animal material
One hundred and ninety-two adult male Sprague-Dawley rats 
weighing 180-220 g were used for the experiments. They were 
procured from the Animal House of the College of Medicine, 
University of Lagos. They were allowed to acclimatize and 
maintained under standard photoperiodic condition in the Rat 
Room of the Department of Anatomy for two weeks. They were 
allowed unrestricted access to rat chow (Pfizer Mill, Lagos, 
Nigeria) and pipe-borne water in the Anatomy Department. The 
rats were weighed, and randomly divided into three main groups 
(G1-3) of 64 rats each. The animals in the 3 main groups were 
subdivided into 8 subgroups (G1a, G1b, G1c, G1d, G1e, G1f, G1g, 
G1h, G2a…G3h), of 8 rats each. G1 were normoglycaemic, G2, 
hyperglycaemic and G3, diabetic rats. Subgroups a-g were (a) 
control rats treated with intraperitoneal injections of distilled 
water; (b) control rats treated with distilled water via gastric 
intubation; (c)  rats treated orally by gavage with 500 mg/kg body 
weight of aqueous leaf extract of Momordica foetida; (d) rats 
treated orally by gavage with 500 mg/kg body weight of aqueous 
leaf extract of Vernonia amygdalina; (e) rats treated orally by 
gavage with 500 mg/kg body weight of aqueous leaf extract of 
Tapinanthus; (f) rats administered 10 mg/kg of glibenclamide 
orally by gavage; (g) rats given 250 mg/kg of chlorpropamide 
orally by gavage; and (h) those given 0.1 I.U./kg body weight of 
human insulin lente subcutaneously. All animals were observed for 
clinical signs of drug toxicity (such as tremors, weakness, refusal 
of feeds, weight loss, hair-loss, coma and death) throughout the 
duration of the experiment and four weeks thereafter. All 
procedures involving animals in this study conformed to the 
guiding principles for research involving animals as 
recommended by the Declaration of Helsinki and the Guiding 
  Principlesin the Care and Use of Animals (18) and were approved
by the Departmental Committee on the Use and Care of Animals. 
Induction of experimental diabetes
Diabetes was induced (in the group of diabetic rats) with 
alloxan. Crystalline powdered alloxan (2.5 g) (NAFCO Nigeria 
Limited) was taken and dissolved in 62.5 ml of distilled water to 
yield a concentration of 40 mg/ml. One hundred and fifty 
milligrams per kilogram body weight of alloxan was administered 
intraperitoneally (19) to 64 of the animals, after an overnight fast 
(access to only water) of 12 hours to make them more susceptible to 
developing diabetes (20,21). Only rats with serum glucose levels 
greater than 400 mg/dl were used in experiments.
Induction of hyperglycaemic state
Rats were injected 5 g/kg of 50% dextrose in water 
subcutaneously. The hyperglycaemic state was assessed in 
dextrose-treated rats by measuring non-fasting blood 
concentration of glucose 30 minutes post-dextrose injection. Only 
rats with serum glucose levels greater than 110 mg/dl were used in 
experiments. 
Experimental procedure
Touch Basic made by Lifescan (Johnson & Johnson Company, 
California, USA) and the results were read off on the meter 45 
seconds after application of samples to the strips. The technical 
performance of the glucometer used was evaluated by comparison 
with standard laboratory method of blood glucose estimation 
(spectrophotometer) at the beginning, midway and at end of the 
experiment as previously described by Ajala et al., (22).   In order 
to minimize the effects of circadian rhythm on our results, the 
experiment was structured in such a way that the serial blood 
glucose estimation of half of the rats were commenced at 0800h (8 
a.m.) and subsequently at 0900h (9 a.m.), 1100h (11 a.m.), 1300h 
(1 p.m.), 1500h (3 p.m.), 1700h (5 p.m.) and 1900h (7 p.m.),  while 
those of the other half were commenced at 2000h (8 p.m.) and 
subsequently at 2100h (9 p.m.), 2300h (11 p.m.), 0100h (1 a.m.), 
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0300h ( 3 a.m.), 0500h (5 a.m.) and 0700h (7 a.m.). The serial 
blood glucose levels taken were the means of these two divisions. 
We have previously described a circadian rhythm for blood 
glucose concentration in male Sprague-Dawley rats in Lagos, 
with peak at 1900h and nadir at 1100h (23).
Data Analysis
Statistical analysis was performed using Microsoft excel. 
Results were expressed as means ± standard deviation (SD) and 
subjected to statistical analysis using one-way analysis of 
variance (ANOVA) and the Scheffe’s post-hoc test. The 
significance level considered was p < 0.05.  
RESULTS
Activity in normoglycaemic rats
Significant (p< 0.05-0.01) hypoglycaemic effects of the 
extract of Momordica foetida, Vernonia amygdalina and 
Tapinanthus butungii were observed within 4, 10 and 8 hours after 
oral administration (table 1), respectively. The percentage of 
maximum reduction in blood glucose concentrations caused by 
the aqueous leaf extract of Momordica foetida, Vernonia 
amygdalina and Tapinanthus butungii were 22.05, 25.76 and 
17.44%, respectively and these values are statistically (p < 0.001) 
different from those of the controls. 
Activity in hyperglycaemic rats
Significant (p< 0.05) anti-hyperglycaemic effects of the 
extract of Momordica foetida, Vernonia amygdalina and 
Tapinanthus butungii were observed within 4, 6 and 8 hours after 
oral administration (table 2), respectively. The percentage of 
maximum reductions in blood glucose concentrations caused by 
the aqueous leaf extract of Momordica foetida, Vernonia 
amygdalina and Tapinanthus butungii in rats pretreated with 50% 
dextrose were 53.87, 53.61 and 49.50% respectively. These 
reductions caused by the three herbs were comparable (p < 0.05) 
with those caused by glibenclamide and chlorpropamide (table 2).
Activity in alloxan-induced diabetic rats
In the diabetic rats, the aqueous leaf extract of Momordica 
foetida caused a maximum reduction in blood glucose level six 
hours after administration, while that of Vernonia amygdalina was 
ten hours after. The aqueous leaf extract of Tapinanthus butungii 
on the other hand continued to cause reduction after 10 hours of 
administration. Of great significance was that the three extracts 
caused greater blood glucose reductions than glibenclamide and 
chlopropamide in the alloxan-induced diabetic rats, while they 
exhibited significant anti-diabetic effects comparable with that 
insulin lente (table 3). 
Our results also showed that there were no significant 
differences in blood glucose levels of rats that had distilled water 
intraperitoneally and those that were similarly treated by gastric 
intubation (tables 1-3). 
There were no obvious signs of toxicity (such as tremors, 
weakness, refusal of feeds, weight loss, hair-loss, coma and death) 
observed in any of the animals throughout the duration of our 
observation.
Table 1: Effects of aqueous leaf extract of  Momordica foetida (500 mg/kg, per oral), Vernonia amygdalina (500 mg/kg, per oral), 
Tapinanthus butungii (500 mg/kg, per oral), glibenclamide (10 mg/kg, per oral), chlorpropamide (250 mg/kg, per oral) and 
human insulin lente (0.1 I.U./kg, subcutaneously) on blood glucose on blood glucose concentrations of normoglycaemic rats (mg/dl)
Group Beforetrea-tment After treatment MR % MR
(n=8) 0h 1h 2h 4h 6h 8h 10h 12h
COIP 72.90±5.45 73.96±6.02 72.01±5.11 73.48±5.45 73.23±5.34 74.49±5.68 73.49±5.39 75.34±5.83 0.89 1.22
COGI 73.23±5.35 73.95±5.55 74.43±5.75 72.37±5.24 73.98±5.61 75.07±6.46 73.67±5.38 75.90±6.09 0.86 1.17
MF 69.15±5.32 71.25±4.23 65.48±4.16 54.46±4.45** 53.98±4.47** 53.90±4.21** 55.48±4.30** 55.65±4.37** 15.25*** 22.05***
VA 73.45±5.32 72.37±5.13 70.36±5.75 62.41±4.98 54.53±4.76 64.57±4.69 62.35±4.71* 60.45±3.51* 18.92*** 25.76***
TB 72.65±5.04 73.56±5.31 68.45±5.03 63.45±4.85 62.85±4.37* 62.56±4.57* 59.98±3.98* 61.35±4.95* 12.67*** 17.44***
GC 71.87±4.98 63.18±4.01 57.82±3.87* 56.68±3.31* 54.56±3.47** 49.89±2.98** 57.56±3.51* 57.56±3.36* 21.98*** 30.58***
CP 72.56±5.16 60.73±3.45* 56.73±3.46* 50.43±2.98** 50.96±3.01** 55.72±3.45* 59.36±3.86* 60.38±3.53* 22.13*** 30.50***
IL 73.87±5.57 45.57±2.56*** 39.97±2.28*** 41.26±2.35*** 54.36±3.31** 63.36±4.28 68.15±4.29 69.73±4.02 33.90*** 45.89***
Table 2: Effects of aqueous leaf extract of  Momordica foetida (500 mg/kg, per oral), Vernonia amygdalina (500 mg/kg, per oral), 
Tapinanthus butungii(500 mg/kg, per oral), glibenclamide (10 mg/kg, per oral), chlorpropamide (250 mg/kg, per oral) and 
human insulin lente (0.1 I.U./kg, subcutaneously) on blood glucose on blood glucose concentrations of hyperglycaemic rats (mg/dl)
Group Before treatment After treatment MR % MR
(n=8) 0h 1h 2h 4h 6h 8h 10h 12h
COIP 117.45±10.01 80.32±7.38 75.48±6.03 74.57±5.76 73.48±4.65 73.91±4.45 74.00±5.05 72.96±5.15 44.49 37.88
COGI 116.28±9.98 79.98±6.98 74.65±6.21 74.23±5.02 73.45±5.43 73.51±5.15 73.79±5.17 71.94±5.11 44.34 38.13
MF 118.17±9.51 71.03±6.92 65.45±4.99 56.17±4.47* 55.90±4.67* 54.56±4.45* 54.51±4.54* 56.24±4.56* 63.66* 53.87*
VA 117.86±9.45 72.49±6.42 71.48±5.45 67.57±5.06 61.32±4.56* 58.43±4.55* 57.35±4.65* 54.67±3.87* 63.19* 53.61*
TB 119.27±10.01 76.42±6.75 72.46±5.34 68.32±5.01 65.38±4.76 63.36±4.65* 61.01±3.56* 60.23±4.71* 59.04* 49.50*
GC 117.23±9.48 68.69±5.43 58.77±4.82* 56.11±3.83* 52.43±3.77* 50.56±3.53** 58.05±4.78* 56.64±4.21* 66.67* 56.87*
CP 115.57±9.13 65.43±5.21 55.46±3.86* 51.25±3.45** 51.38±3.54** 55.43±3.85* 58.55±3.76* 62.34±4.76 64.32* 55.66*
IL 118.35±9.46 55.01±3.42** 44.57±3.21*** 44.10±3.28*** 55.66±3.76** 61.54±4.05* 67.89±5.12 68.99±5.21 74.25** 62.74**
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Table 3: Effects of aqueous leaf extract of Momordica foetida (500 mg/kg, per oral), Vernonia amygdalina (500 mg/kg, per oral), Tapinanthus butungii
 (500 mg/kg, per oral), glibenclamide (10 mg/kg, per oral), chlorpropamide (250 mg/kg, per oral) and human insulin lente (0.1 I.U./kg, 
subcutaneously) on blood glucose on blood glucose concentrations of diabetic rats (mg/dl)
Group Before treatment  After treatment MR % MR
(n=8) 0h 1h 2h 4h 6h 8h 10h 12h
COIP 501.23±14.01 501.07±14.54 545.49±15.68 555.24±15.32 545.28±15.44 564.68±15.81 566.58±15.86 578.42±15.98 0.16 0.03
COG 519.34±14.01 522.39±14.11 518.99±14.27 524.75±15.48 537.18±15.34 554.02±15.56 555.49±15.65 566.17±15.89 0.35 0.07
MF 483.50±16.11 478.70±15.21 387.73±14.20* 324.33±14.4** 155.70±9.51*** 262.8±10.90** 275.54±11.33** 298.40±12.11** 338.8*** 70.07***
VA 502.77±15.98 487.98±14.23 466.87±14.76* 383.23±13.04** 324.63±10.34** 210.13±9.90*** 191.78±9.23*** 192.49±9.56*** 310.99*** 61.86***
TB 530.49±15.34 473.11±14.59 375.45±14.32* 255.34±10.21** 212.89±10.21** 172.38±10.34*** 162.10±9.01*** 145.20±8.56*** 385.29*** 72.63***
GC 519.35±15.35 469.87±14.42 523.23±15.64 517.53±15.38 495.57±15.24 485.64±14.49 463.01±14.01 465.19±14.25 60.22 11.51
CP 482.34±14.27 516.56±15.01 499.67±15.11 474.21±15.02 421.31±14.45 467.90±14.73 499.92±12.21 455.62±14.68 95.25 18.44
IL 526.57±15.18 165.86±8.50*** 155.45±7.56*** 317.37±12.65* 343.28±13.84* 466.39±14.49 498.59±15.12 501.46±15.21 371.12*** 70.48***
Legend for tables 1-3
Values given represent the means±SD (standard deviation) of 8 
observations
*:p<0.05; **:p<0.01; ***: p<0.001
MR: Maximum reduction of blood glucose concentration
COIP: Control group of rats that had 2 ml/kg of distilled water 
intraperitoneally
COGI: Control group of rats that had 2 ml/kg of distilled water via 
gastric intubation
MF: Group of rats that had aqueous leaf extract of Momordica 
foetida 
VA: Group of rats that were treated with aqueous leaf extract 
of Vernonia amygdalina 
TB: Group of rats that were treated with aqueous leaf extract 
of Tapinanthus butungii 
GC: Group of rats that were administered glibenclamide
CP: Group of rats that were treated with chlorpropamide
TB: Group of rats that were administered human insulin lente
DISCUSSION
Though, insulin is presently one of the most important 
therapeutic agents known to medicine, efforts have continued to 
seek for insulin substitutes from plant sources for the treatment of 
diabetes mellitus (24). It is clear from the results of this 
experimental animal study that the tested aqueous leaf extracts of 
Momordica foetida, Vernonia amygdalina and Tapinanthus 
butungii induced significant reductions (p<0.05-0.001) in blood 
glucose concentrations of normoglycaemic, hyperglycaemic and 
alloxan-induced diabetic rats. The findings of this investigation 
may suggest that the plant extracts could, at least in part, stimulate 
insulin production and glucose utilization, like glibenclamide and 
chlorpropamide, to bring about their blood glucose reductions in 
this mammalian experimental model used.  It was observed that 
aqueous leaf extract of Momordica foetida has faster onset of 
hypoglycaemic and anti-hyperglycaemic actions than those of 
Vernonia amygdalina and Tapinanthus butungii, while 
Tapinanthus butungii has a longer anti-diabetic action than 
Momordica foetida and Vernonia amygdalina. It was also noted 
that the leaf extracts of Momordica foetida and Vernonia 
amygdalina were more effective in lowering blood glucose levels 
than Tapinanthus butungii in normoglycaemic and 
hyperglycaemic rats, while that of Tapinanthus butungii was more 
effective than the other two in  the diabetic rats. The three herbs 
investigated had more anti-diabetic effects than glibenclamide 
and chlorpropamide, while having comparable effects with 
insulin lente. The fact that these extracts caused significant 
reductions in blood glucose levels in alloxan-induced diabetic rats 
suggests that these plants may act in yet undetermined ways aside 
stimulating insulin production from the pancreatic islets since the 
latter would have been severely damaged by alloxan. However, 
stimulation of the undamaged or residual pancreatic islets to 
produce insulin cannot be ruled out since both glibenclamide and 
chlorpropamide caused slight but insignificant reductions in 
blood glucose levels in alloxan-induced diabetic rats. Although 
these present findings are suggestive of relative differences in the 
hypoglycaemic, anti-hyperglycaemic and anti-diabetic efficacies 
in the fresh leaves of Momordica foetida, Vernonia amygdalina 
and Tapinanthus butungii (at single doses), the reasons and 
precise mechanism for these differences require further studies for 
appropriate elucidation. Further studies will also incorporate 
varying doses of the three herbs, comparison of their ED  doses, 50
measurements of serum insulin levels and evaluation of lipid 
profiles in the animals.
CONCLUSIONS
The results of this experimental animal study suggest that 
aqueous leaf extract of Momordica foetida has faster onset of 
actions (hypoglycaemic and anti-hyperglycaemic) than those of 
Vernonia amygdalina and Tapinanthus butungii at the doses used. 
Our results suggest that aqueous leaf extract of Tapinanthus 
butungii has a longer anti-diabetic action than Momordica foetida 
and Vernonia amygdalina at the doses compared. This animal 
study also suggest that at these single dosages of the extracts, 
aqueous leaf extracts of Momordica foetida and Vernonia 
amygdalina are more effective in lowering blood glucose than 
Tapinanthus butungii in normoglycaemic and hyperglycaemic 
rats, while that of Tapinanthus butungii is more effective than the 
other two in diabetic rats. 
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